A reconciliation of the numerators and the denominators of the basic and dilutive net income per common share computations are as follows (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Numerator:
Net income	$	19,186	$	14,701	$	37,859	$	22,691

Denominator:
Weighted average basic common shares outstanding		35,178		36,327		35,560		36,104
Effect of dilutive securities:
Options to purchase common stock		375		636		403		670
Restricted stock units		606		1,051		585		1,067
Weighted average diluted common shares outstanding		36,159		38,014		36,548		37,841

The Company excluded the following potential common shares, presented based on weighted average shares outstanding during the periods, from the computation of diluted net income per share because including them would have had an anti-dilutive effect (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Options to purchase common stock		—		3		—		3
Restricted stock units		226		11		240		12
		226		14		240		15

The tables above do not include performance-based awards for which the performance conditions had not been met as of period end. As of June 30, 2026 and 2025, the Company had outstanding pRSUs for which the performance conditions had not been met as of period end of 444,218 and 922,016, respectively.